Advertisement

Topics

Search Results for "Breast Pap Test Trial"

13:10 EDT 29th March 2017 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Experts present triple-negative breast cancer immunotherapy trial

A researcher from University Hospitals Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at the 2016 San Antonio Breast Cancer Symposium. T...

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Kornblum speaks with ecancer at the San Antonio Breast Cancer Symposium 2016 about results from the PrECOB 0102 trial, a randomised, double-blind phase II trial of everolimus vs placebo in combin...

UH Seidman cancer center expert presents triple-negative breast cancer immunotherapy trial

(University Hospitals Cleveland Medical Center) A researcher from UH Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at 2016 San Antonio ...

FALCON Breast Cancer Trial: Who's Naive Here?

In the FALCON trial, fulvestrant improved PFS in ER+ metastatic breast cancer patients who were endocrine-therapy naive, but the trial failed to answer key clinical questions, says Dr Lidia Schapira. ...

TEAM IIb trial results: Adjuvant ibandronate in early breast cancer

Prof Linn presents data at the 2016 San Antonio Breast Cancer Symposium from the TEAM IIb trial, in which post-menopausal women with hormone receptor positive breast cancer, with no metastases, wer...

Oncotype DX test can help guide treatment decisions and enable personalized care before breast cancer surgery

New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherap...

ECOG-ACRIN begins site recruitment for TMIST breast imaging trial

(ECOG-ACRIN Cancer Research Group) TMIST will enroll 165,000 asymptomatic women in the US and Canada, between the ages of 45 and 74, to compare the incidence of advanced cancers in those screened for ...

Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer 20162020 Prices from USD $800

Scope of the ReportThe report entitled Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer 20162020, provides analysis of the global cancer diagnostics market and the US cancer diagno...

Matching PubMed Articles

Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.

Prognostic factors of ipsilateral breast tumor recurrence (IBTR) may change over time following breast-conserving therapy.

A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.

Glucocorticoid receptor (GR) overexpression is associated with poor prognosis ER-negative breast cancer. GR antagonism with mifepristone increases chemotherapy-induced breast cancer cell death, theref...

Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer.

Accelerated partial breast irradiation (APBI) is emerging as an alternative to whole-breast irradiation. This study presents the results of a prospective trial evaluating 3-dimensional conformal radio...

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.

SUPREMO is a phase 3 randomised trial evaluating radiotherapy post-mastectomy for intermediate-risk breast cancer. 1688 patients were enrolled from 16 countries between 2006 and 2013. We report the re...

No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.

Breast-conserving surgery (BCS) followed by radiotherapy (RT) is an established treatment for women with T1-2N0 breast cancers. Since subgroups of patients have low ipsilateral breast tumour recurrenc...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement